Search

Your search keyword '"Krause, Bernd-J."' showing total 483 results
Start Over Author "Krause, Bernd-J."
483 results on '"Krause, Bernd-J."'

1. PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.

Author

Fendler, Wolfgang P, Eiber, Matthias, Beheshti, Mohsen, Bomanji, Jamshed, Calais, Jeremie, Ceci, Francesco, Cho, Steve Y, Fanti, Stefano, Giesel, Frederik L, Goffin, Karolien, Haberkorn, Uwe, Jacene, Heather, Koo, Phillip J, Kopka, Klaus, Krause, Bernd J, Lindenberg, Liza, Marcus, Charles, Mottaghy, Felix M, Oprea-Lager, Daniela E, Osborne, Joseph R, Piert, Morand, Rowe, Steven P, Schöder, Heiko, Wan, Simon, Wester, Hans-Jürgen, Hope, Thomas A, and Herrmann, Ken

Subjects
Humans, Prostatic Neoplasms, Gallium Radioisotopes, Edetic Acid, Oligopeptides, Male, Positron Emission Tomography Computed Tomography, Guideline, PET, PSMA, Prostate cancer, Restaging, Staging, Biomedical Imaging, Urologic Diseases, Aging, Prostate Cancer, Cancer, Other Physical Sciences, Clinical Sciences, Nuclear Medicine & Medical Imaging
Abstract

Here we aim to provide updated guidance and standards for the indication, acquisition, and interpretation of PSMA PET/CT for prostate cancer imaging. Procedures and characteristics are reported for a variety of available PSMA small radioligands. Different scenarios for the clinical use of PSMA-ligand PET/CT are discussed. This document provides clinicians and technicians with the best available evidence, to support the implementation of PSMA PET/CT imaging in research and routine practice.

Published
2023

6. Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial

Author

Fizazi, Karim, Herrmann, Ken, Krause, Bernd J, Rahbar, Kambiz, Chi, Kim N, Morris, Michael J, Sartor, Oliver, Tagawa, Scott T, Kendi, Ayse T, Vogelzang, Nicholas, Calais, Jeremie, Nagarajah, James, Wei, Xiao X, Koshkin, Vadim S, Beauregard, Jean-Mathieu, Chang, Brian, Ghouse, Ray, DeSilvio, Michelle, Messmann, Richard A, and de Bono, Johann

Published
2023
Full Text
View/download PDF

7. DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment

Author

Bernhardt, Denise, König, Laila, Grosu, Anca-L., Rieken, Stefan, Krieg, Sandro M., Wick, Wolfgang, Wiestler, Benedikt, Schmidt-Graf, Friederike, Sahm, Felix, Gempt, Jens, Meyer, Bernhard, Krause, Bernd J., Petersen, Cordula, Fietkau, Rainer, Thomas, Michael, Giordano, Frank, Wittig-Sauerwein, Andrea, Debus, Jürgen, Tabatabai, Ghazaleh, Hau, Peter, Steinbach, Joachim, and Combs, Stephanie E.

Published
2022
Full Text
View/download PDF

8. DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis

Author

Bernhardt, Denise, König, Laila, Grosu, Anca, Wiestler, Benedikt, Rieken, Stefan, Wick, Wolfgang, Gempt, Jens, Krieg, Sandro M., Schmidt-Graf, Friederike, Sahm, Felix, Meyer, Bernhard, Krause, Bernd J., Petersen, Cordula, Fietkau, Rainer, Thomas, Michael, Giordano, Frank, Wittig-Sauerwein, Andrea, Debus, Jürgen, Tabatabai, Ghazaleh, Hau, Peter, Steinbach, Joachim, and Combs, Stephanie E.

Published
2022
Full Text
View/download PDF

12. Correlation analyses of radiographic progression‐free survival with clinical and health‐related quality of life outcomes in metastatic castration‐resistant prostate cancer: Analysis of the phase 3 VISION trial.

Author

Morris, Michael J., de Bono, Johann, Nagarajah, James, Sartor, Oliver, Wei, Xiao X., Nordquist, Luke T., Koshkin, Vadim S., Chi, Kim N., Krause, Bernd J., Herrmann, Ken, Rahbar, Kambiz, Vickers, Adrian, Mirante, Osvaldo, Ghouse, Ray, Fizazi, Karim, and Tagawa, Scott T.

Subjects
CLINICAL trials, OVERALL survival, QUALITY of life, CASTRATION-resistant prostate cancer, STATISTICAL correlation, FUNCTIONAL assessment, PROSTATE cancer, SENSE of coherence
Abstract

Background: [177Lu]Lu–PSMA‐617 (177Lu‐PSMA‐617) plus protocol‐permitted standard of care (SOC) prolonged overall survival (OS) and radiographic progression‐free survival (rPFS) versus SOC in patients with prostate‐specific membrane antigen (PSMA)–positive metastatic castration‐resistant prostate cancer (mCRPC) in the phase 3 VISION study, in addition to beneficial effects on symptomatic skeletal events (SSEs) and health‐related quality of life (HRQOL). Methods: Post hoc analyses used the full analysis set from the VISION study (N = 831) overall and by randomized treatment arm (177Lu‐PSMA‐617 plus SOC, n = 551; SOC, n = 280). Correlations were determined between OS and rPFS and between rPFS or OS and time to SSE or to worsening HRQOL (Functional Assessment of Cancer Therapy–Prostate [FACT‐P] and 5‐level EQ‐5D [EQ‐5D‐5L]). Correlation analyses used an iterative multiple imputation copula‐based approach (correlation coefficients [rho] of <0.3 were defined as weak, ≥0.3 and <0.5 as mild, ≥0.5 and <0.7 as moderate, and ≥0.7 as strong). Results: In the overall population, rPFS correlated strongly with OS (rho, ≥0.7). Correlations between rPFS or OS and time to SSE without death were weak or mild. Time to worsening in the FACT‐P total score and emotional and physical well‐being domains correlated mildly or moderately with rPFS and moderately with OS. Correlation coefficients for time‐to‐worsening EQ‐5D‐5L scores were mild to moderate for both rPFS and OS. Correlation coefficients were similar between treatment arms. Conclusions: In this analysis of the VISION study, rPFS correlated strongly with OS but not with time to SSE or worsening HRQOL. These findings require further investigation. In patients with metastatic castration‐resistant prostate cancer participating in the VISION randomized phase 3 trial, radiographic progression‐free survival correlated strongly with overall survival but not with time to a first symptomatic skeletal event or worsening health‐related quality of life or pain. There were no clear or consistent differences in the strengths of correlation between the two treatment groups ([177Lu]Lu‐PSMA‐617 plus protocol‐permitted standard of care vs. standard of care alone). [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

13. FDG PET Hybrid Imaging

Author

Becker, Juliane, Schwarzenböck, Sarah M., Krause, Bernd J., Krämer, Alwin, Series Editor, Lu, Jiade J., Series Editor, Schober, Otmar, editor, Kiessling, Fabian, editor, and Debus, Jürgen, editor

Published
2020
Full Text
View/download PDF

14. Response Assessment and Follow-Up by Imaging in GU Tumours

Author

Draulans, Cédric, Schoots, Ivo G., Krause, Bernd J., Isebaert, Sofie, Heijmink, Stijn W. T. P. J., Nitsch, Sascha, Haustermans, Karin, Schwarzenböck, Sarah M., Kauczor, Hans-Ulrich, Series Editor, Parizel, Paul M., Series Editor, Peh, Wilfred C. G., Series Editor, Brady, Luther W., Honorary Editor, Lu, Jiade J., Series Editor, Beets-Tan, Regina G.H., editor, Oyen, Wim J. G., editor, and Valentini, Vincenzo, editor

Published
2020
Full Text
View/download PDF

16. Markov Random Field Segmentation of Brain MR Images

Author

Held, Karsten, Kops, Elena Rota, Krause, Bernd J., Wells III, William M., Kikinis, Ron, and Mueller-Gaertner, Hans-Wilhelm

Subjects
Computer Science - Computer Vision and Pattern Recognition, Condensed Matter - Statistical Mechanics, Physics - Data Analysis, Statistics and Probability, Physics - Medical Physics
Abstract

We describe a fully-automatic 3D-segmentation technique for brain MR images. Using Markov random fields the segmentation algorithm captures three important MR features, i.e. non-parametric distributions of tissue intensities, neighborhood correlations and signal inhomogeneities. Detailed simulations and real MR images demonstrate the performance of the segmentation algorithm. The impact of noise, inhomogeneity, smoothing and structure thickness is analyzed quantitatively. Even single echo MR images are well classified into gray matter, white matter, cerebrospinal fluid, scalp-bone and background. A simulated annealing and an iterated conditional modes implementation are presented. Keywords: Magnetic Resonance Imaging, Segmentation, Markov Random Fields, Comment: 34 pages, 10 figures; the paper (published in 1997) has introduced the concept of Markov random field to the segmentation of medical MR images. For the published version see http://dx.doi.org/10.1109/42.650883

Published
2009
Full Text
View/download PDF

18. Patient-Orientated Evaluation of Treatment of Non-Melanoma Skin Cancer with Rhenium-188 Compared to Surgery.

Author

Krönert, Maila I. C., Schwarzenböck, Sarah M., Kurth, Jens, Heuschkel, Martin, Krause, Bernd J., Emmert, Steffen, and Tietze, Julia K.

Subjects
CONSERVATIVE treatment, SKIN tumors, RHENIUM, AESTHETICS, RESEARCH funding, PILOT projects, QUESTIONNAIRES, CANCER patient medical care, DESCRIPTIVE statistics, RADIOISOTOPES, IMMUNE system, HYPOPIGMENTATION, OPERATIVE surgery, GUMS & resins, COMPARATIVE studies, DATA analysis software, WOUND care, RADIODERMATITIS
Abstract

Background: Non-melanoma skin cancers (NMSCs) are responsible for up to one-third of all human malignancies. Surgery is usually the treatment of choice, but patients often experience pain during the procedure. Topical rhenium-188 resin skin cancer treatment (RSCT) may be a valid therapeutic alternative. Methods: In this monocentric pilot study, 19 patients suffering from NMSC were treated with RSCT. Most of these patients had also experienced surgery, either because they developed a new NMSC in aftercare, or they had suffered previously from NMSC. Three RSCT-treated patients, who had no exposure to surgery so far, were paired with three matched patients, who had received surgery. We sought to evaluate and compare the patients' experience with both treatments. A questionnaire assessed patients' perceptions regarding side effects, aesthetic outcomes, wound care, fear of complications, and personal treatment preferences. Patients evaluated the different parameters of their either RSCT- or surgery-treated lesions on a scale from 0–10. Results: Patients were more afraid of complications before surgery than before RSCT (p = 0.04). Treatment with RSCT caused significantly less pain on treatment day (mean 0.56) than surgery (mean 2.32) (0 no pain, 10 maximum pain) (p = 0.02) and 14 days after the procedure (mean 0.89 versus mean 2.47) (p = 0.02). On day 14, RSCT-treated lesions were also significantly less itchy (mean 0.34) than after surgery (mean 1.50). Most patients were very satisfied with the aesthetic outcome after both RSCT (mean 8.42) and surgery (mean 8.31) (p = 0.89). In the case of a new NMSC, the majority of patients who experienced both treatments would rather be treated primarily with RSCT (44%) or would consider both options (31%); only 19% preferred surgery. Conclusion: Patients evaluated RSCT as less painful than surgery. The aesthetic outcomes of both treatments were comparable. For pain-sensitive patients, RSCT might be a preferable treatment option. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

20. Patient‐related benefits of amyloid PET imaging in unclear dementia: rationale and study design of the randomized ENABLE study

Author

Grazia, Alice, primary, Spottke, Annika, additional, Boecker, Henning, additional, Daamen, Marcel, additional, Graf, Erika, additional, Sahlmann, Jörg, additional, Buchert, Ralph, additional, Mohnike, Wolfgang, additional, Mohnike, Konrad, additional, Kurth, Jens, additional, Jessen, Frank, additional, Krause, Bernd J, additional, and Teipel, Stefan, additional

Published
2023
Full Text
View/download PDF

23. Patient‐related benefits of amyloid PET imaging in dementia: Rationale and design of the German randomized coverage with evidence development study ENABLE

Author

Teipel, Stefan J., primary, Spottke, Annika, additional, Boecker, Henning, additional, Daamen, Marcel, additional, Graf, Erika, additional, Sahlmann, Jörg, additional, Buchert, Ralph, additional, Mohnike, Wolfgang, additional, Mohnike, Konrad, additional, Kurth, Jens, additional, Jessen, Frank, additional, and Krause, Bernd J., additional

Published
2023
Full Text
View/download PDF

29. Die Medizinische Fakultät Rostock 2018

Author

Reisinger, Emil C., primary, Altiner, Attila, additional, Krause, Bernd J., additional, Mlynski, Robert, additional, Schlensog, Wiebke, additional, Borowski, Katrin, additional, Müller, Annett, additional, and Jeguschke, Harald, additional

Published
2019
Full Text
View/download PDF

31. A VISION Substudy of Reader Agreement on68Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for177Lu-PSMA-617 Radioligand Therapy

Author

Kuo, Phillip H., primary, Yoo, Don C., additional, Avery, Ryan, additional, Seltzer, Marc, additional, Calais, Jeremie, additional, Nagarajah, James, additional, Weber, Wolfgang A., additional, Fendler, Wolfgang P., additional, Hofman, Michael S., additional, Krause, Bernd J., additional, Brackman, Marcia, additional, Kpamegan, Euloge, additional, Ghebremariam, Samson, additional, Benson, Taylor, additional, Catafau, Ana M., additional, and Kendi, Ayse T., additional

Published
2023
Full Text
View/download PDF

32. Altered limbic functional connectivity in individuals with subjective cognitive decline: Converging and diverging findings across Chinese and German cohorts

Author

Jiang, Xueyan, primary, Hu, Xiaochen, additional, Daamen, Marcel, additional, Wang, Xiaoqi, additional, Fan, Chunqiu, additional, Meiberth, Dix, additional, Spottke, Annika, additional, Roeske, Sandra, additional, Fliessbach, Klaus, additional, Spruth, Eike Jakob, additional, Altenstein, Slawek, additional, Lohse, Andrea, additional, Hansen, Niels, additional, Glanz, Wenzel, additional, Incesoy, Enise I., additional, Dobisch, Laura, additional, Janowitz, Daniel, additional, Rauchmann, Boris‐Stephan, additional, Ramirez, Alfredo, additional, Kilimann, Ingo, additional, Munk, Matthias H., additional, Wang, Xiao, additional, Schneider, Luisa‐Sophie, additional, Gabelin, Tatjana, additional, Roy, Nina, additional, Wolfsgruber, Steffen, additional, Kleineidam, Luca, additional, Hetzer, Stefan, additional, Dechent, Peter, additional, Ewers, Michael, additional, Scheffler, Klaus, additional, Amthauer, Holger, additional, Buchert, Ralph, additional, Essler, Markus, additional, Drzezga, Alexander, additional, Rominger, Axel, additional, Krause, Bernd J., additional, Reimold, Matthias, additional, Priller, Josef, additional, Schneider, Anja, additional, Wiltfang, Jens, additional, Buerger, Katharina, additional, Perneczky, Robert, additional, Teipel, Stefan, additional, Laske, Christoph, additional, Peters, Oliver, additional, Düzel, Emrah, additional, Wagner, Michael, additional, Jiang, Jiehui, additional, Jessen, Frank, additional, Boecker, Henning, additional, and Han, Ying, additional

Published
2023
Full Text
View/download PDF

33. Altered limbic functional connectivity in individuals with subjective cognitive decline: Converging and diverging findings across Chinese and German cohorts

Author

Jiang, Xueyan, Hu, Xiaochen, Daamen, Marcel, Wang, Xiaoqi, Fan, Chunqiu, Meiberth, Dix, Spottke, Annika, Roeske, Sandra, Fliessbach, Klaus, Spruth, Eike Jakob, Altenstein, Slawek, Lohse, Andrea, Hansen, Niels, Glanz, Wenzel, Incesoy, Enise I, Dobisch, Laura, Janowitz, Daniel, Rauchmann, Boris-Stephan, Ramirez, Alfredo, Kilimann, Ingo, Munk, Matthias H, Wang, Xiao, Schneider, Luisa-Sophie, Gabelin, Tatjana, Roy, Nina, Wolfsgruber, Steffen, Kleineidam, Luca, Hetzer, Stefan, Dechent, Peter, Ewers, Michael, Scheffler, Klaus, Amthauer, Holger, Buchert, Ralph, Essler, Markus, Drzezga, Alexander, Rominger, Axel, Krause, Bernd J, Reimold, Matthias, Priller, Josef, Schneider, Anja, Wiltfang, Jens, Buerger, Katharina, Perneczky, Robert, Teipel, Stefan, Laske, Christoph, Peters, Oliver, Düzel, Emrah, Wagner, Michael, Jiang, Jiehui, Jessen, Frank, Boecker, Henning, and Han, Ying

Subjects
hippocampus, Epidemiology, Health Policy, functional connectivity, 610 Medicine & health, insula, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, amyloid deposition, cross-cultural harmonization, ddc:610, Neurology (clinical), Centiloid, subjective cognitive decline, Geriatrics and Gerontology
Abstract

INTRODUCTION: It remains unclear whether functional brain networks are consistently altered in individuals with subjective cognitive decline (SCD) of diverse ethnic and cultural backgrounds and whether the network alterations are associated with an amyloid burden.METHODS: Cross-sectional resting-state functional magnetic resonance imaging connectivity (FC) and amyloid-positron emission tomography (PET) data from the Chinese Sino Longitudinal Study on Cognitive Decline and German DZNE Longitudinal Cognitive Impairment and Dementia cohorts were analyzed.RESULTS: Limbic FC, particularly hippocampal connectivity with right insula, was consistently higher in SCD than in controls, and correlated with SCD-plus features. Smaller SCD subcohorts with PET showed inconsistent amyloid positivity rates and FC-amyloid associations across cohorts.DISCUSSION: Our results suggest an early adaptation of the limbic network in SCD, which may reflect increased awareness of cognitive decline, irrespective of amyloid pathology. Different amyloid positivity rates may indicate a heterogeneous underlying etiology in Eastern and Western SCD cohorts when applying current research criteria. Future studies should identify culture-specific features to enrich preclinical Alzheimer's disease in non-Western populations.HIGHLIGHTS: Common limbic hyperconnectivity across Chinese and German subjective cognitive decline (SCD) cohorts was observed. Limbic hyperconnectivity may reflect awareness of cognition, irrespective of amyloid load. Further cross-cultural harmonization of SCD regarding Alzheimer's disease pathology is required.

Published
2023
Full Text
View/download PDF

36. Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions

Author

Fanti, Stefano, Minozzi, Silvia, Morigi, Joshua James, Giesel, Frederik, Ceci, Francesco, Uprimny, Christian, Hofman, Michael S., Eiber, Matthias, Schwarzenbock, Sarah, Castellucci, Paolo, Bellisario, Cristina, Chauvie, Stéphane, Bergesio, Fabrizio, Emmett, Louise, Haberkorn, Uwe, Virgolini, Irene, Schwaiger, Markus, Hicks, Rodney J., Krause, Bernd J., and Chiti, Arturo

Published
2017
Full Text
View/download PDF

40. Therapiesteuerung in der Hämatologie und Onkologie.

Author

Westphalen, C. Benedikt, Krause, Bernd J., Schuler, Markus, Brucker, Sara Y., Hartkopf, Andreas, Rasche, Leo, Saußele, Susanne, Wörmann, Bernhard, Hecken, Josef, and Danner, Martin

Abstract

Die diesjährige Frühjahrstagung der DGHO (Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e. V.) stand unter der Überschrift «Herausforderungen in der Onkologie – personalisierte Therapiesteuerung». Über drei Themenkomplexe hinweg wurden aktuelle Möglichkeiten und Perspektiven der Therapiesteuerung in der Onkologie hinsichtlich «Methoden», gelungenen «Beispielen» sowie der «Umsetzung in der Versorgung» diskutiert. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

41. Translational assessment of a DATA-functionalized FAP inhibitor with facile 68Ga-labeling at room temperature.

Author

Escudero-Castellanos, Alondra, Kurth, Jens, Imlimthan, Surachet, Menéndez, Elena, Pilatis, Eirinaios, Moon, Euy Sung, Läppchen, Tilman, Rathke, Hendrik, Schwarzenböck, Sarah M., Krause, Bernd J., Rösch, Frank, Rominger, Axel, and Gourni, Eleni

Subjects
BLADDER, PROSTATE cancer patients, HEART, ABSORBED dose, URINARY organs, ORGANS (Anatomy), STROMAL cells
Abstract

Purpose: The present study aims at evaluating the preclinical and the clinical performance of [68Ga]Ga-DATA5m.SA.FAPi, which has the advantage to be labeled with gallium-68 at room temperature. Methods: [68Ga]Ga-DATA5m.SA.FAPi was assessed in vitro on FAP-expressing stromal cells, followed by biodistribution and in vivo imaging on prostate and glioblastoma xenografts. Moreover, the clinical assessment of [68Ga]Ga-DATA5m.SA.FAPi was conducted on six patients with prostate cancer, aiming on investigating, biodistribution, biokinetics, and determining tumor uptake. Results: [68Ga]Ga-DATA5m.SA.FAPi is quantitatively prepared in an instant kit-type version at room temperature. It demonstrated high stability in human serum, affinity for FAP in the low nanomolar range, and high internalization rate when associated with CAFs. Biodistribution and PET studies in prostate and glioblastoma xenografts revealed high and specific tumor uptake. Elimination of the radiotracer mainly occurred through the urinary tract. The clinical data are in accordance with the preclinical data concerning the organ receiving the highest absorbed dose (urinary bladder wall, heart wall, spleen, and kidneys). Different to the small-animal data, uptake of [68Ga]Ga-DATA5m.SA.FAPi in tumor lesions is rapid and stable and tumor-to-organ and tumor-to-blood uptake ratios are high. Conclusion: The radiochemical, preclinical, and clinical data obtained in this study strongly support further development of [68Ga]Ga-DATA5m.SA.FAPi as a diagnostic tool for FAP imaging. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

44. The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the “evidence-based” refusal to endorse them by EANM due to the “not evidence-based” marginalization of the role of Nuclear Medicine

Author

Treglia, Giorgio, Aktolun, Cumali, Chiti, Arturo, Frangos, Savvas, Giovanella, Luca, Hoffmann, Martha, Iakovou, Ioannis, Mihailovic, Jasna, Krause, Bernd J., Langsteger, Werner, Verburg, Frederik A., Luster, Markus, and on behalf of the EANM and the EANM Thyroid Committee

Published
2016
Full Text
View/download PDF

45. Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer

Author

Verburg, Frederik A., Aktolun, Cumali, Chiti, Arturo, Frangos, Savvas, Giovanella, Luca, Hoffmann, Martha, Iakovou, Ioannis, Mihailovic, Jasna, Krause, Bernd J., Langsteger, Werner, Luster, Markus, and on behalf of the EANM and the EANM Thyroid Committee

Published
2016
Full Text
View/download PDF

49. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

Author

Boellaard, Ronald, Delgado-Bolton, Roberto, Oyen, Wim J. G., Giammarile, Francesco, Tatsch, Klaus, Eschner, Wolfgang, Verzijlbergen, Fred J., Barrington, Sally F., Pike, Lucy C., Weber, Wolfgang A., Stroobants, Sigrid, Delbeke, Dominique, Donohoe, Kevin J., Holbrook, Scott, Graham, Michael M., Testanera, Giorgio, Hoekstra, Otto S., Zijlstra, Josee, Visser, Eric, Hoekstra, Corneline J., Pruim, Jan, Willemsen, Antoon, Arends, Bertjan, Kotzerke, Jörg, Bockisch, Andreas, Beyer, Thomas, Chiti, Arturo, and Krause, Bernd J.

Published
2015
Full Text
View/download PDF

50. [177Lu]Lu-PSMA-617 in PSMA-positive metastatic castration-resistant prostate cancer: Prior and concomitant treatment subgroup analyses of the VISION trial.

Author

Vaishampayan, Nitin, primary, Morris, Michael J., additional, Krause, Bernd J., additional, Vogelzang, Nicholas J., additional, Kendi, Ayse T., additional, Nordquist, Luke T., additional, Calais, Jeremie, additional, Nagarajah, James, additional, Beer, Tomasz M., additional, El-Haddad, Ghassan, additional, Brackman, Marcia, additional, Desilvio, Michelle, additional, Messmann, Richard Adam, additional, Sartor, A. Oliver, additional, and Fizazi, Karim, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results